Advertisement
Screener

BioLineRx Ltd. (BLRX) Form 6-K: Report of foreign private issuer, 2022

BioLineRx Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2022-12-20: Form 6-K; Period of report 2022-12-20; Description 6-K; Document zk2228896.htm.
  • 2022-11-15: Form 6-K; Period of report 2022-11-15; Description 6-K; Document zk2228748.htm.
  • 2022-11-10: Form 6-K; Period of report 2022-11-10; Description 6-K; Document zk2228696.htm.
  • 2022-11-04: Form 6-K; Period of report 2022-11-04; Description 6-K; Document zk2228653.htm.
FiledFormPeriod of reportDescriptionDocument
2022-12-206-K2022-12-206-Kzk2228896.htm
2022-11-156-K2022-11-156-Kzk2228748.htm
2022-11-106-K2022-11-106-Kzk2228696.htm
2022-11-046-K2022-11-046-Kzk2228653.htm
2022-11-036-K2022-11-036-Kzk2228647.htm
2022-09-276-K2022-09-276-Kzk2228508.htm
2022-09-216-K2022-09-216-Kzk2228489.htm
2022-09-196-K2022-09-196-Kzk2228483.htm
2022-09-156-K2022-09-156-Kzk2228476.htm
2022-09-126-K2022-09-126-Kzk2228456.htm
2022-08-166-K2022-06-306-Kzk2228327.htm
2022-07-056-K2022-07-056-Kzk2228089.htm
2022-06-286-K2022-06-286-Kzk2228056.htm
2022-06-166-K2022-06-166-Kzk2228009.htm
2022-05-276-K2022-05-276-Kzk2227915.htm
2022-05-116-K2022-05-116-Kzk2227778.htm
2022-03-166-K2022-03-166-Kzk2227490.htm
2022-03-036-K2022-03-036-Kzk2227405.htm
2022-01-246-K2022-01-246-Kzk2227090.htm
2022-01-186-K2022-01-186-Kzk2227069.htm